Sarah Pirrie

Colleges, School and Institutes

View graph of relations

Most downloaded publications

Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)
Lazaros Andronis, Ilias Goranitis, Sarah Pirrie & 2 others, , Apr 2017, In: BJU international. 119, 4, p. 522-529 8 p.

Research output: Contribution to journal › Article › peer-review

244 downloads
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification
Douglas Ward, Becky Boucher, Sarah Pirrie, Joanne Stockton, Andrew Beggs, Nicholas James, Maurice Zeegers, KK Cheng & Rik Bryan, Sep 2019, In: BJU international. 124, 3, p. 532-544 13 p.

Research output: Contribution to journal › Article › peer-review

176 downloads
Total fluid intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study
Raoul Reulen, Sarah Pirrie, Nicholas James, Rik Bryan, KK Cheng & Maurice Zeegers, 30 Jul 2018, In: Bladder Cancer. 4, 3, p. 303-310 8 p.

Research output: Contribution to journal › Article › peer-review

164 downloads
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
Rik Bryan, Sarah Pirrie, Adam Devall, KK Cheng, Maurice Zeegers, Nicholas James & Douglas Ward, 17 Mar 2015, In: British Journal of Cancer. 112, 6, p. 1052-8 7 p.

Research output: Contribution to journal › Article › peer-review

119 downloads
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
Rik Bryan, Neil Shimwell, Wenbin Wei, Adam Devall, Sarah Pirrie, Nicholas James, Maurice Zeegers, Ka Cheng, Ashley Martin & Douglas Ward, 4 Feb 2014, In: British Journal of Cancer. 110, 3, p. 679-85 7 p.

Research output: Contribution to journal › Article › peer-review

116 downloads

Recent publications

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
Sarah Pirrie, Eszter Nagy, Keith Wheatley, 14 Sep 2020, In: British Journal of Haematology.

Research output: Contribution to journal › Article › peer-review

Breast cancer index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—to offer more? (aTTom) trial
Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, Nov 2019, In: Annals of Oncology. 30, 11, p. 1776-1783 8 p.

Research output: Contribution to journal › Article › peer-review

Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification
Douglas Ward, Becky Boucher, Sarah Pirrie, Joanne Stockton, Andrew Beggs, Nicholas James, Maurice Zeegers, KK Cheng & Rik Bryan, Sep 2019, In: BJU international. 124, 3, p. 532-544 13 p.

Research output: Contribution to journal › Article › peer-review

View all (24)